Active Research Protocols
- 08-N-0044 – A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)
- 09-C-0243 – A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children with Recurrent/Refractory CNS Tumors
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014